Board Meeting2 Nov 2026, 06:32 pm
JHS Svendgaard Board Approves Unaudited Financials
AI Summary
JHS Svendgaard Laboratories Ltd announced that its Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The board meeting, held on November 2, 2026, also included the approval of the Limited Review Report on these financial results. Additionally, the board approved the appointment of Mr. Pardeep Kumar Bhardwaj as an Additional (Non-Executive Independent) Director.
Key Highlights
- Board approved unaudited standalone and consolidated financials.
- Results are for the quarter and half-year ended September 30, 2026.
- Limited Review Report also approved.
- Appointment of an Additional Director was approved.
- Board meeting concluded on November 2, 2026.
Price Impact
More from JHS